|
Manufacturer¿s reference number: (b)(4).Since the device has not been returned for analysis, no product failure analysis can be conducted, and no determination of possible contributing factors can be made.As such, the investigation will be closed.If the complaint device is received in the future, the investigation will be reopened and conducted as appropriate.Since no lot number was provided, no manufacturing record evaluation could be performed.Reason for reoperation: reoperation under general anesthesia took place as a result of the adverse event of chronic seroma that occurred immediately post surgery reported.(b)(4).Mentor's manufacturer's report numbers: 1645337-2020-11861, 1645337-2020-11863, 1645337-2020-11865, 1645337-2020-11868, 1645337-2020-11869, 1645337-2020-11871, 1645337-2020-11872.Are related to the same incident.
|
|
This complaint is from a literature source.It was reported that 1 patient underwent immediate fat grafting for latissumus dorsi only breast reconstruction and suffered chronic seroma in the donor site.Intervention was reoperation under general anesthesia.This reported event occurred immediately after the procedure.Additional information was received from the corresponding author on 09/08/2020 stating the reported patient consequences were attributed to the procedure and not to the medical devices used.However, assignment of the root cause for the event remains inconclusive and therefore a 3500a will be submitted out of an abundance of caution.Other mentor devices that were also used in this study: none.Non-mentor devices that were also used in this study: mercedes-type cannula (3 mm 932 cm), b-braun 10cc syringes, thermo scientific fixed-rotor centrifuge.Publication details: title: safety of large-volume immediate fat grafting for latissimus dorsi-only breast reconstruction: results and related complications in 95 consecutive cases.Objective: to study if breast reconstruction using latissimus dorsi and immediate fat grafting (lifg) is a widely applicable technique for those cases in which an autologous reconstruction is desirable, but the use of microsurgical perforator flaps is not available.Methods: data of 95 consecutive breast reconstructions from (b)(6) 2014 to (b)(6) 2018 were prospectively collected.All patients included in the study had a minimum follow-up of one year after completion of the reconstructive process.
|